NCT06350201

Brief Summary

To breakthrough the bottleneck identified, we will conduct a cross-sectional study to develop a symptom clustering model for depression and anxiety. A wide range of statistical methods as well as machine learning approaches were explored, and a cohesive hierarchical clustering algorithm will be used. After developing the model, a symptom-matched intervention program based on problem solving therapy will be formulated. We are supposed to examine whether its use for personalizing symptom-matched psychological treatment can lead to improved patient outcomes, compared with usual care. This project is expected to provide a new and precise method for the emotion management, which will provide a standardized intervention pathway combining screening with treatment for the management of depression symptom and anxiety symptom. A preciser intervention matched to individual symptoms may provide important insight in improving patient outcome as well as a standardized mood management pathway targeting to the early detection and intervention for community residents.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
380

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Sep 2025Dec 2026

First Submitted

Initial submission to the registry

April 1, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 5, 2024

Completed
1.4 years until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

January 8, 2026

Status Verified

January 1, 2026

Enrollment Period

8 months

First QC Date

April 1, 2024

Last Update Submit

January 6, 2026

Conditions

Keywords

machine learning approachCBTPSTdepressionanxiety

Outcome Measures

Primary Outcomes (2)

  • The Patient Health Questionnaire (PHQ-9)

    Baseline, week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8, week 12, week 20, week 32

  • GAD-7

    Baseline, week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8, week 12, week 20, week 32

Secondary Outcomes (3)

  • PSQI

    Baseline, week 1, week 4, week 6, week 8, week 12, week 20, week 32

  • WHODAS 2.0

    Baseline, week 1, week 4, week 6, week 8, week 12, week 20, week 32

  • EQ-5D-5L

    Baseline, week 1, week 4, week 6, week 8, week 12, week 20, week 32

Other Outcomes (2)

  • remission rate

    week 8, week 12, week 20, week 32

  • SBQ-R

    week -1 pre-screening

Study Arms (2)

8 weeks Problem-solving therapy

EXPERIMENTAL

Problem-solving therapy imparts problem-solving abilities applicable to participants' daily lives. Personalized therapies, including brief behavioral treatment of insomnia, mindfulness, and physical exercise suggestions, were tailored to correspond with patients' specific clusters of sadness and anxiety symptoms.

Behavioral: problem solving therapy

treatment as usual

PLACEBO COMPARATOR

Care as usual with the PST-PC learning manual and generic information from the same domains (BBTI, mindfulness, and physical activity) included in the intervention group's daily check-ins

Other: control group

Interventions

Problem-solving therapy-based holistic emotion management interventions matched to individual symptoms

8 weeks Problem-solving therapy

Routine psychological care and guidance on mood management

treatment as usual

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Aged between 18 and 64 years. PHQ-9 ≥10 and/or GAD-7 ≥8 at baseline assessment defined as the threshold for caseness.

You may not qualify if:

  • People will be excluded if they meet any of the following criteria:
  • They are receiving psychological therapy during an interview for any mental health issue;
  • currently acutely suicidal or have attempted suicide in the past 2 months, as indicated by PHQ-9 item 9;
  • cognitively impaired or diagnosed with bipolar disorder or psychosis or experiencing psychotic symptoms; d) dependent on alcohol or drugs; e) living with an unstable or acute medical illness that would interfere with trial participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Renmin Hospital of Wuhan University

Wuhan, China

RECRUITING

MeSH Terms

Conditions

DepressionAnxiety Disorders

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2024

First Posted

April 5, 2024

Study Start

September 1, 2025

Primary Completion

May 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

January 8, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations